Ro 09-0198
| Internal ID | 35517f29-9f00-460c-bb3d-3fd1085e77e2 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | (1S,4S,13S,16S,19S,22S,25S,28R,31S,37S,40S,41S,44R,47S,50S,53S,56R,65S,70S)-44-amino-37-(2-amino-2-oxoethyl)-50-(3-amino-3-oxopropyl)-4,16,22-tribenzyl-47-(3-carbamimidamidopropyl)-31-[(S)-carboxy(hydroxy)methyl]-41,70-dimethyl-2,5,8,14,17,20,23,26,29,32,35,38,45,48,51,54,57,67-octadecaoxo-25-propan-2-yl-42,69,72-trithia-3,6,9,15,18,21,24,27,30,33,36,39,46,49,52,55,58,60,66-nonadecazapentacyclo[38.18.9.319,56.328,53.09,13]triheptacontane-65-carboxylic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C89H125N25O25S3/c1-43(2)66-84(133)109-59-41-140-40-58-79(128)108-60-42-142-45(4)68(86(135)105-55(75(124)110-66)34-48-22-12-7-13-23-48)111-76(125)54(33-47-20-10-6-11-21-47)104-82(131)61-26-17-31-114(61)65(118)38-98-72(121)53(32-46-18-8-5-9-19-46)103-78(127)57(106-80(60)129)36-95-29-15-14-24-52(87(136)137)102-85(134)67(112-77(126)56(35-63(92)116)99-64(117)37-97-83(132)69(113-81(59)130)70(119)88(138)139)44(3)141-39-49(90)71(120)100-50(25-16-30-96-89(93)94)73(122)101-51(74(123)107-58)27-28-62(91)115/h5-13,18-23,43-45,49-61,66-70,95,119H,14-17,24-42,90H2,1-4H3,(H2,91,115)(H2,92,116)(H,97,132)(H,98,121)(H,99,117)(H,100,120)(H,101,122)(H,102,134)(H,103,127)(H,104,131)(H,105,135)(H,106,129)(H,107,123)(H,108,128)(H,109,133)(H,110,124)(H,111,125)(H,112,126)(H,113,130)(H,136,137)(H,138,139)(H4,93,94,96)/t44-,45-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58+,59-,60-,61-,66-,67+,68+,69-,70-/m0/s1 |
| InChI Key | QJDWKBINWOWJNZ-XNGLKPBDSA-N |
| Popularity | 23 references in papers |
| Molecular Formula | C89H125N25O25S3 |
| Molecular Weight | 2041.30 g/mol |
| Exact Mass | 2039.8440581 g/mol |
| Topological Polar Surface Area (TPSA) | 872.00 Ų |
| XlogP | -9.40 |
| Atomic LogP (AlogP) | -10.08 |
| H-Bond Acceptor | 29 |
| H-Bond Donor | 27 |
| Rotatable Bonds | 19 |
| 110655-58-8 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5110 | 51.10% |
| Caco-2 | - | 0.8605 | 86.05% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Lysosomes | 0.4125 | 41.25% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8255 | 82.55% |
| OATP1B3 inhibitior | + | 0.9346 | 93.46% |
| MATE1 inhibitior | - | 0.8200 | 82.00% |
| OCT2 inhibitior | - | 0.7000 | 70.00% |
| BSEP inhibitior | + | 0.9691 | 96.91% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8858 | 88.58% |
| CYP3A4 substrate | + | 0.7467 | 74.67% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8115 | 81.15% |
| CYP3A4 inhibition | - | 0.9399 | 93.99% |
| CYP2C9 inhibition | - | 0.8420 | 84.20% |
| CYP2C19 inhibition | - | 0.7935 | 79.35% |
| CYP2D6 inhibition | - | 0.8861 | 88.61% |
| CYP1A2 inhibition | - | 0.8741 | 87.41% |
| CYP2C8 inhibition | + | 0.8231 | 82.31% |
| CYP inhibitory promiscuity | - | 0.9719 | 97.19% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.9000 | 90.00% |
| Carcinogenicity (trinary) | Non-required | 0.5916 | 59.16% |
| Eye corrosion | - | 0.9851 | 98.51% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.7593 | 75.93% |
| Skin corrosion | - | 0.9223 | 92.23% |
| Ames mutagenesis | - | 0.7000 | 70.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6981 | 69.81% |
| Micronuclear | + | 0.8500 | 85.00% |
| Hepatotoxicity | - | 0.6161 | 61.61% |
| skin sensitisation | - | 0.8332 | 83.32% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.9444 | 94.44% |
| Mitochondrial toxicity | + | 0.9500 | 95.00% |
| Nephrotoxicity | - | 0.9015 | 90.15% |
| Acute Oral Toxicity (c) | III | 0.5666 | 56.66% |
| Estrogen receptor binding | - | 0.4826 | 48.26% |
| Androgen receptor binding | + | 0.7450 | 74.50% |
| Thyroid receptor binding | + | 0.7602 | 76.02% |
| Glucocorticoid receptor binding | + | 0.8228 | 82.28% |
| Aromatase binding | + | 0.8084 | 80.84% |
| PPAR gamma | + | 0.7459 | 74.59% |
| Honey bee toxicity | - | 0.6507 | 65.07% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5700 | 57.00% |
| Fish aquatic toxicity | + | 0.8971 | 89.71% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.94% | 83.82% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.85% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.72% | 96.09% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 98.70% | 90.17% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.50% | 85.14% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 97.18% | 93.00% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 97.10% | 97.64% |
| CHEMBL228 | P31645 | Serotonin transporter | 96.85% | 95.51% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.53% | 97.09% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 96.24% | 96.67% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.71% | 94.45% |
| CHEMBL4071 | P08311 | Cathepsin G | 95.27% | 94.64% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 95.18% | 85.00% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.43% | 91.11% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 93.91% | 90.24% |
| CHEMBL1628481 | P35414 | Apelin receptor | 93.31% | 97.89% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.80% | 95.89% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 92.20% | 94.45% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 91.86% | 95.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.84% | 96.47% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 91.75% | 80.71% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 91.57% | 97.14% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.36% | 95.56% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 90.63% | 90.71% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 89.78% | 99.23% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 89.56% | 93.03% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 89.27% | 82.38% |
| CHEMBL2093869 | P05106 | Integrin alpha-IIb/beta-3 | 89.14% | 95.42% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 88.93% | 96.33% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 88.76% | 97.33% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 88.69% | 98.24% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 88.48% | 95.50% |
| CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 87.44% | 94.36% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 87.29% | 95.83% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 85.32% | 98.33% |
| CHEMBL2535 | P11166 | Glucose transporter | 84.54% | 98.75% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 84.45% | 95.89% |
| CHEMBL4447 | Q9Y337 | Kallikrein 5 | 84.17% | 87.50% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 84.00% | 90.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 83.98% | 90.08% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 83.95% | 100.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.65% | 96.90% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 83.07% | 92.97% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 82.79% | 97.05% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 82.77% | 96.11% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 81.99% | 96.03% |
| CHEMBL222 | P23975 | Norepinephrine transporter | 81.90% | 96.06% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 81.31% | 99.09% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 80.74% | 97.25% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 80.41% | 100.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 133562644 |
| LOTUS | LTS0155296 |
| wikiData | Q104394114 |